The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2006
Filed:
Mar. 02, 2001
Kenya Shitara, Machida, JP;
Nobuo Hanai, Machida, JP;
Emi Shoji, Machida, JP;
Mikiko Sakurada, Machida, JP;
Akiko Furuya, Machida, JP;
Kazuyasu Nakamura, Machida, JP;
Rinpei Niwa, Machida, JP;
Kenji Shibata, Machida, JP;
Motoo Yamasaki, Machida, JP;
Kenya Shitara, Machida, JP;
Nobuo Hanai, Machida, JP;
Emi Shoji, Machida, JP;
Mikiko Sakurada, Machida, JP;
Akiko Furuya, Machida, JP;
Kazuyasu Nakamura, Machida, JP;
Rinpei Niwa, Machida, JP;
Kenji Shibata, Machida, JP;
Motoo Yamasaki, Machida, JP;
Kyowa Hakko Kogyo Co., Ltd., Tokyo, JP;
Abstract
A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.